Global Intraocular Lens Market Size Grows at a CAGR of 4.72%

Introduction

Straits Research released its highly anticipated report, “Global Intraocular Lens Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 4.78 billion in 2025 and is projected to expand to USD 7.20 billion by 2034, registering a compound annual growth rate (CAGR) of 4.72%.

Market Dynamics

The growth of the global intraocular lens market is driven by the rising prevalence of cataract surgeries in emerging economies, where increasing healthcare infrastructure and greater awareness of vision correction procedures are enabling more patients to access surgical interventions. Additionally, the growing geriatric population, combined with higher disposable income in developing regions, is contributing to increased adoption of both standard and premium IOLs. For example, initiatives to improve eye care services in countries such as India, Brazil, and China are facilitating large-scale cataract screening programs and subsidized surgical procedures, allowing more patients to benefit from vision-restoring interventions. The adoption of minimally invasive surgical techniques, including femtosecond laser-assisted cataract surgery, is also enhancing surgical outcomes and patient satisfaction, further supporting market growth.

However, the high costs associated with premium IOLs, such as multifocal and toric lenses, restrict accessibility for patients in low and middle-income regions. Even though these lenses offer superior visual outcomes and reduce dependence on corrective eyewear, their price often makes them unaffordable for a large segment of the population. Consequently, while the market is poised for growth, affordability, infrastructure limitations, and patient education remain key challenges that manufacturers and healthcare providers must address to achieve broader adoption of advanced intraocular lens technologies.

Market Highlights

• Product Type: The premium IOL segment is expected to register the fastest CAGR growth of 5.81%.
• End Use: The hospitals segment dominated the market with a revenue share of 48.37% in 2025.
• Regional Insights: North America dominated the global market, accounting for a 37.43% share in 2025. This growth is attributed to government-led blindness control programs and the increasing availability of advanced premium intraocular lenses.

Competitive Players

1. Alcon Inc.
2. Johnson & Johnson Vision Care, Inc.
3. Bausch + Lomb Incorporated
4. Carl Zeiss Meditec AG
5. HOYA Corporation
6. Rayner Group
7. Eyekon Medical
8. Lenstec, Inc.
9. STAAR SURGICAL
10. HumanOptics Holding AG
11. Ophtec
12. USIOL Inc.
13. Innexus
14. Oculentis GmbH
15. Physiol S.A.
16. Cooper Companies, Inc.
17. Glaukos Corporation
18. EssilorLuxottica S.A.
19. Santen Pharmaceutical Co., Ltd.
20. Others

Recent Developments

Segmentation

1. By Product Type (2026-2034)
   1. Monofocal IOL
   2. Premium IOL
   3. Multifocal
   4. Toric
   5. Accommodating
   6. Phakic Intraocular Lens (PIOL)
   7. Others
2. By End Use (2026-2034)
   1. Hospitals
   2. Ophthalmic Clinics
   3. Ambulatory Surgery Centers
   4. Others